• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Opiant Pharmaceuticals

Indivior Sublocade opioid use disorder treatment box
Pharma

Indivior grounds schizophrenia drug, triggering 130 layoffs

Indivior has slashed its projected revenue increase for 2024 from 18% to 8%, citing competitive pressure for top-selling product Sublocade.
Kevin Dunleavy Jul 10, 2024 11:39am
FDA

Indivior's overdose rescue spray Opvee crosses FDA finish line

May 23, 2023 2:42pm
Pharmacist filling prescription in pharmacy - stock photo CaiaimageAgnieszka WozniaGetty Images

FDA moves to boost access to overdose reversal med

Nov 16, 2022 7:15am
MA

Indivior inks $145M Opiant buyout for nasal opioid overdose drug

Nov 15, 2022 9:25am
cash

BARDA backs Opiant to get overdose drug over the FDA line

Aug 9, 2022 10:28am
Opiant

Opiant races to FDA after nasal overdose drug matches Narcan

May 3, 2022 9:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings